NOTCH1 and breast carcinoma: ASPH-mediated upregulation of Notch1 signaling by hydroxylation of Notch1 and its ligands has been detected in various cancer types, such as hepatocellular carcinoma (HCC) 8, pancreatic cancer 10, and breast cancer 11.